Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy

L Dhungel, ME Rowsey, C Harris, D Raucher - Molecules, 2024 - mdpi.com
Glioblastoma multiforme (GBM), a grade IV (WHO classification) malignant brain tumor,
poses significant challenges in treatment. The current standard treatment involves surgical …

[HTML][HTML] Prognostic values and immune infiltration of KLF15, AQP7, AGPAT9 in glioma and glioblastoma

AM Olajuyin, OS Nwachukwu… - Future Journal of …, 2024 - fjps.springeropen.com
The overall survival of patients with lower-grade gliomas and glioblastoma varies greatly. No
reliable or existing procedures can accurately forecast survival and prognostic biomarkers …

Endothelial-secreted Endocan protein acts as a PDGFR alpha ligand and regulates vascularity, radioresistance, and regional phenotype in glioblastoma

S Bastola, MS Pavlyukov, Y Ghochani, N Sharma… - bioRxiv, 2020 - biorxiv.org
Glioblastoma is a lethal brain cancer with active infiltration of tumor cells at the periphery
where the vascular supply is enriched to create its own niche. Given that tumor recurrence is …